| Bioactivity | Angiogenesis agent 1 (compound C-31) is a salidroside-derivated glycoside analogue. Angiogenesis agent 1 is an activator of the HIF-1α pathway. Angiogenesis agent 1 has the potential for the research of diabetic hind limb ischemia[1]. |
| Name | Angiogenesis agent 1 |
| Formula | C20H24O7 |
| Molar Mass | 376.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu C, et al. Discovery of Salidroside-Derivated Glycoside Analogues as Novel Angiogenesis Agents to Treat Diabetic Hind Limb Ischemia. J Med Chem. 2022;65(1):135-162. |
Angiogenesis agent 1
CAS: F: C20H24O7 W: 376.40
Angiogenesis agent 1 (compound C-31) is a salidroside-derivated glycoside analogue. Angiogenesis agent 1 is an activator
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.